Patients with AR ITK deficiency present various hematological disorders due to uncontrolled EBV infection, including fatal infectious mononucleosis, lymphoma, lymphoproliferative disease, lymphomatoid granulomatosis, hemophagocytic lymphohistiocytosis, and dysgammaglobulinemia (Huck et al., 2009; Stepensky et al., 2011; Linka et al., 2012; Mansouri et al., 2012; Ghosh et al., 2014; Ghosh et al., 2018; Alme et al., 2015; Bienemann et al., 2015; Cipe et al., 2015; Çaǧdaş et al., 2017; Mo et al., 2019; Youssefian et al., 2019; Eken et al., 2019; Fang et al., 2019; Howe et al., 2019). Here, ITK is linked to dysgammaglobulinemia.